Novartis AG Stock Price and Value Analysis

Should you buy Novartis AG stock? (NYSE:NVS). Let's see how it does in our automated value investing analysis system.

  • This company has stable growth.
  • This company has a large dividend yield!
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.

Inside the NVS Numbers

NVS Price
(Novartis AG stock price per share)
[?] PE Ratio versus Sector 28% higher than other Healthcare stocks
[?] PE Ratio versus Industry 3% lower than other Unknown stocks
[?] Cash Yield 4.12%
[?] Free Cash Flow Jitter 19%
[?] Dividend Yield 4%
Shares Shorted 6,084,440

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 6,084,440 shares shorted. With 2,080,580,040 shares available for purchase and an average trading volume over the past 10 trading days of 1,865,590, it would take at least 3.261 days for all of the short holders to cover their shorts.

Is Novartis AG Stock on Sale?

Based on our analysis, we believe that you should not buy Novartis AG right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy NVS Stock?

Does Novartis AG have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.